A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine

Expression of human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma (PDAC) has been postulated to be a marker of sensitivity to gemcitabine. However, heterogeneity in the studies attempting to quantify hENT1 expression in patients with PDAC treated with gemcitabine...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalloger, Steve E, Riazy, Maziar, Tessier‐Cloutier, Basile, Karasinska, Joanna M, Gao, Dongxia, Peixoto, Renata D, Samimi, Setareh, Chow, Christine, Wong, Hui‐Li, Mackey, John R, Renouf, Daniel J, Schaeffer, David F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527321/
https://www.ncbi.nlm.nih.gov/pubmed/28770102
http://dx.doi.org/10.1002/cjp2.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527321/
https://www.ncbi.nlm.nih.gov/pubmed/28770102
http://dx.doi.org/10.1002/cjp2.75

Ejemplares similares